title: Aprotinin use in patients with dialysis-dependent renal failure undergoing cardiac operations.
authors.affiliation: Legacy Good Samaritan Hospital, Portland, OR, USA.
authors.forename: J H
authors.initials: JH
authors.lastname: Lemmer
authors.forename: M T
authors.initials: MT
authors.lastname: Metzdorff
authors.forename: A H
authors.initials: AH
authors.lastname: Krause
authors.forename: J E
authors.initials: JE
authors.lastname: Okies
authors.forename: T A
authors.initials: TA
authors.lastname: Molloy
authors.forename: J G
authors.initials: JG
authors.lastname: Hill
authors.forename: W B
authors.initials: WB
authors.lastname: Long
authors.forename: T R
authors.initials: TR
authors.lastname: Winkler
authors.forename: U S
authors.initials: US
authors.lastname: Page
mesh_terms: D000368:Aged; D007611:Aprotinin / Q000627:therapeutic use*; D016063:Blood Loss, Surgical / Q000517:prevention & control*; D005260:Female; D006331:Heart Diseases / Q000150:complications* / Q000601:surgery*; D006490:Hemostatics / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D008875:Middle Aged; D010530:Peritoneal Dialysis; D006435:Renal Dialysis; D012189:Retrospective Studies; D016896:Treatment Outcome
chemical_list: D006490:Hemostatics; D007611:Aprotinin